Journal articleNEJM Evid · June 2026
BACKGROUND: Prior analyses of trials comparing direct oral anticoagulants (DOACs) to warfarin in atrial fibrillation (AF) have not routinely incorporated patient preferences, despite substantial variation in how patients value the trade-off between outcome ...
Full textLink to itemCite
Journal articleJ Biopharm Stat · October 2025
Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understan ...
Full textLink to itemCite
Journal articleClinical lymphoma, myeloma & leukemia · August 2025
PurposeBelantamab mafodotin is an anti-B cell maturation antigen (BCMA) immunoconjugate for patients with relapsed/refractory multiple myeloma (RRMM). Additional data on its treatment patterns, efficacy, and tolerability in real-world settings are ...
Full textCite
Journal articleJournal of Clinical Oncology · June 1, 2024
e19507 Background: Belamaf is an anti-B cell maturation antigen immunoconjugate for relapsed/refractory multiple myeloma that has shown efficacy and safety in the DREAMM clinical trials. Additional long-term real-world data on it ...
Full textCite
Journal articleJournal of Curriculum and Teaching · January 1, 2024
This is the first in a multi-part series on teaching statistical inference to physician-scientists training to work as members of interdisciplinary scientific teams. This unique student audience has greater scientific sophistication than a typical statisti ...
Full textCite